Cite
Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials.
MLA
Wright, R.Scott, et al. “Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials.” Journal of the American College of Cardiology, vol. 82, no. 24, Dec. 2023, pp. 2251–61. EBSCOhost, https://doi.org/10.1016/j.jacc.2023.10.007.
APA
Wright, R. S., Koenig, W., Landmesser, U., Leiter, L. A., Raal, F. J., Schwartz, G. G., Lesogor, A., Maheux, P., Stratz, C., Zang, X., & Ray, K. K. (2023). Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials. Journal of the American College of Cardiology, 82(24), 2251–2261. https://doi.org/10.1016/j.jacc.2023.10.007
Chicago
Wright, R Scott, Wolfgang Koenig, Ulf Landmesser, Lawrence A Leiter, Frederick J Raal, Gregory G Schwartz, Anastasia Lesogor, et al. 2023. “Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials.” Journal of the American College of Cardiology 82 (24): 2251–61. doi:10.1016/j.jacc.2023.10.007.